OTCMKTS:NDVAF - Indiva Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.62
  • Forecasted Upside: 138.92 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.26
+0.30 (1.20%)

This chart shows the closing price for NDVAF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Indiva Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NDVAF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NDVAF

Analyst Price Target is $0.62
▲ +138.92% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Indiva in the last 3 months. The average price target is $0.62, with a high forecast of $0.62 and a low forecast of $0.62. The average price target represents a 138.92% upside from the last price of $0.26.

This chart shows the closing price for NDVAF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 contributing investment analysts is to buy stock in Indiva.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/1/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/1/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/30/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/28/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/26/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/26/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/25/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/25/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/26/2020Fundamental ResearchReiterated RatingBuy$0.62
(Data available from 7/25/2016 forward)
Indiva logo
Indiva Limited operates as a licensed producer of cannabis products in Canada. It creates premium pre-rolls, flower, capsules, and edible products, as well as provides production and manufacturing services to peer entities. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Ruby Cannabis Sugar, Sapphire Cannabis Salt, Artisan Batch, and other powered by INDIVA products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.
Read More

Today's Range

Now: $0.26
Low: $0.25
High: $0.28

50 Day Range

MA: $0.30
Low: $0.25
High: $0.36

52 Week Range

Now: $0.26
Low: $0.15
High: $0.58

Volume

22,727 shs

Average Volume

184,578 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Indiva?

The following Wall Street research analysts have issued reports on Indiva in the last twelve months: Fundamental Research.
View the latest analyst ratings for NDVAF.

What is the current price target for Indiva?

1 Wall Street analysts have set twelve-month price targets for Indiva in the last year. Their average twelve-month price target is $0.62, suggesting a possible upside of 138.9%. Fundamental Research has the highest price target set, predicting NDVAF will reach $0.62 in the next twelve months. Fundamental Research has the lowest price target set, forecasting a price of $0.62 for Indiva in the next year.
View the latest price targets for NDVAF.

What is the current consensus analyst rating for Indiva?

Indiva currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe NDVAF will outperform the market and that investors should add to their positions of Indiva.
View the latest ratings for NDVAF.

What other companies compete with Indiva?

How do I contact Indiva's investor relations team?

The company's listed phone number is 888 649 6686. The official website for Indiva is www.indiva.com.